These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10753007

  • 1. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data.
    Wylie ME, Miller MD, Shear MK, Little JT, Mulsant BH, Pollock BG, Reynolds CF.
    J Geriatr Psychiatry Neurol; 2000; 13(1):43-8. PubMed ID: 10753007
    [Abstract] [Full Text] [Related]

  • 2. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R.
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [Abstract] [Full Text] [Related]

  • 3. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH.
    Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885
    [Abstract] [Full Text] [Related]

  • 4. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA, Saeed SA, Bruce TJ.
    J Clin Psychiatry; 1996 Apr; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [Abstract] [Full Text] [Related]

  • 5. Management of comorbid anxiety and depression.
    Zajecka JM, Ross JS.
    J Clin Psychiatry; 1995 Apr; 56 Suppl 2():10-3. PubMed ID: 7844101
    [Abstract] [Full Text] [Related]

  • 6. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA, Bullock T, Fineberg N.
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract] [Full Text] [Related]

  • 7. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epidemiological data of patients treated with fluvoxamine: results from a 12 week non-comparative multicentre study.
    Dewulf L, Hendrickx B, Lesaffre E.
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():67-72. PubMed ID: 7622826
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.
    Baetz M, Bowen RC.
    Can J Psychiatry; 1998 Feb; 43(1):73-7. PubMed ID: 9494751
    [Abstract] [Full Text] [Related]

  • 14. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH, Dunner DL.
    Depress Anxiety; 2008 Feb; 25(2):91-7. PubMed ID: 17311265
    [Abstract] [Full Text] [Related]

  • 15. Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.
    Koran LM, Bromberg D, Hornfeldt CS, Shepski JC, Wang S, Hollander E.
    Compr Psychiatry; 2010 Feb; 51(4):373-9. PubMed ID: 20579510
    [Abstract] [Full Text] [Related]

  • 16. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C, Schulberg HC, Shear MK.
    Anxiety; 1996 Feb; 2(5):210-8. PubMed ID: 9160625
    [Abstract] [Full Text] [Related]

  • 17. The Yale-Brown Obsessive Compulsive Scale. II. Validity.
    Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1989 Nov; 46(11):1012-6. PubMed ID: 2510699
    [Abstract] [Full Text] [Related]

  • 18. Acute treatment response in outpatients with panic disorder: high versus low depressive symptoms.
    Black DW, Wesner R, Bowers W, Monahan P, Gabel J.
    Ann Clin Psychiatry; 1995 Dec; 7(4):181-8. PubMed ID: 8721892
    [Abstract] [Full Text] [Related]

  • 19. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA, Schweizer E, Rickels K.
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [Abstract] [Full Text] [Related]

  • 20. Anxious depression.
    Lydiard RB, Brawman-Mintzer O.
    J Clin Psychiatry; 1998 Jun; 59 Suppl 18():10-7. PubMed ID: 9840193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.